Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03147430 · ClinicalTrials.gov registry record
Early Detection of Breast Cancer in Women With Suspicious Mammograms
A clinical trial of Breast Cancer, sponsored by Sentara Norfolk General Hospital.
- Active
- Registry status
- 270
- Enrollment target
- 2
- Study locations
NCT03147430 is a study of Breast Cancer that is active but no longer recruiting, run by Sentara Norfolk General Hospital. The registered enrollment target is 270 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT03147430, a study of Breast Cancer, is active but no longer recruiting, sponsored by Sentara Norfolk General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 270 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a non-treatment study. It will not involve the use of any investigational drug or device. Potential participants will be enrolled through direct contact with collaborating clinical sites when the patient's annual 3D mammogram report yields a BIRADS rating of 4-5. The clinical Investigators or a member of their staff will conduct consent discussion once a suspicious mammogram report is identified or if a patient is referred for imaging of a suspicious area in the breast. After consenting the participant will be asked to donate a blood sample, a saliva sample, medical records pertaining to the suspicious mammogram report and a medical history questionnaire. The participants will be followed after one year to capture progression or resolution of their suspicious mammogram report. After a biopsy confirms the diagnosis of cancer or benign lesion, a recut sample of the tissue may be requested for research.
Conditions Studied
Interventions
- OTHER Biomarkers
Study Locations (2)
Virginia
- Dorothy G Hoefer Comprehensive Breast Center - Newport News
- Sentara Norfolk General Breast Center - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2017-05-08 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03147430
The ClinicalTrials.gov registry entry for NCT03147430 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (90% lower). The listed sponsor is Sentara Norfolk General Hospital, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Biomarkers is the first listed.
NCT03147430 reports 2 study locations spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT03147430 about?
NCT03147430 is a clinical study titled "Early Detection of Breast Cancer in Women With Suspicious Mammograms". This is a non-treatment study. It will not involve the use of any investigational drug or device. Potential participants will be enrolled through direct contact with collaborating clinical sites when the patient's annual 3D mammogram report yields a BIRADS rating of 4-5. The clinical Investigators o...
What is the current status of trial NCT03147430?
This trial is currently active not recruiting. The enrollment target is 270 participants. The study started on 2017-05-08. Estimated completion is 2025-12-31.
What conditions does trial NCT03147430 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT03147430?
The interventions under investigation include: Biomarkers (OTHER).
Who is sponsoring clinical trial NCT03147430?
This trial is sponsored by Sentara Norfolk General Hospital, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03147430 being conducted?
This trial has 2 study locations across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.